Full ESSENCE trial results and Research Summary: nej.md/3EVFAFM Join the conversation
Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. American Journal of Lifestyle Medicine , 30 May 2025, Locatelli, Joo Carlos, et al
(3) patients were younger than 18-years-old
Still, one problem observed in people with high blood pressure is that their kidneys seem to hold onto more sodium, which can lead to the body retaining excess water, increasing blood pressure over time 4
Satiety signalling occurs gradually during and after meals, with timing varying based on meal composition, size, and individual factors
The Wegovy pill is the first oral GLP-1 medication approved for weight management, representing a major breakthrough in obesity treatment